enGene Therapeutics (ENGN) Other Non-Current Assets (2022 - 2026)
enGene Therapeutics' Other Non-Current Assets came in at $1.39 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 0.7% from $1.38 million a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Other Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics' Other Non-Current Assets was $1.36 million, down 0.9% from FY2024.
- Other Non-Current Assets carries a three-year compound annual growth rate of 13.2% (FY2022 to FY2025).
- Going back by fiscal year, Other Non-Current Assets was $1.37 million in FY2024 (+47.7%), $930,000 in FY2023 (-1.0%) and $939,000 in FY2022.
- The fiscal Q3 2026 figure represents the highest quarterly Other Non-Current Assets since fiscal Q1 2025.
- Year-over-year, Other Non-Current Assets increased in four of the last eight quarters, with growth averaging 17.3%.
- The fastest year-over-year change in Other Non-Current Assets over five years came in fiscal Q1 2025 (growth of 61.8%), and the weakest in fiscal Q1 2026 (a decline of 12.1%).
- Business Quant data shows ENGN's Other Non-Current Assets at $1.38 million (Q2 2026), $1.39 million (Q1 2026) and $1.36 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 9.94 Bn |
| 10 | enGene Therapeutics | 105.88 Mn | -888.59 Mn | - | 1.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.39 Mn |
| Apr 30, 2026 | 1.38 Mn |
| Jan 31, 2026 | 1.39 Mn |
| Oct 31, 2025 | 1.36 Mn |
| Jul 31, 2025 | 1.38 Mn |
| Apr 30, 2025 | 1.38 Mn |
| Jan 31, 2025 | 1.58 Mn |
| Oct 31, 2024 | 1.37 Mn |
| Jul 31, 2024 | 1.38 Mn |
| Apr 30, 2024 | 975,000.00 |
| Jan 31, 2024 | 974,000.00 |
| Oct 31, 2023 | 930,000.00 |
| Oct 31, 2022 | 939,000.00 |
API Access
enGene Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();